Yours Free! Top FIVE Dividend Stocks Right Now
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.
Michael J. McBreen net worth and biography

Michael McBreen Biography and Net Worth

Michael McBreen is the executive vice president and president, Codman Specialty Surgical. He is responsible for overall strategic direction and commercial operations of the company’s market leading neurosurgical portfolio and broad surgical instrumentation offering.

Mr. McBreen is a 30-year veteran of the medical device industry. He joined Integra following the acquisition of Codman Neurosurgery from Johnson & Johnson in October 2017. As president of Integra’s international division, he led the expansion of Integra’s business in all regions of the world outside of the United States, representing approximately 30 percent of the company’s overall revenues.

Prior to Integra, Mr. McBreen served as vice president, U.S. commercial and global marketing for Codman neurosurgery and neurovascular businesses. Previously, he was worldwide vice president for professional education for the Johnson & Johnson medical device and diagnostics division. Mr. McBreen also held numerous U.S. and global roles of increasing responsibilities in sales and marketing at DePuy Mitek Sports Medicine, a division of Johnson & Johnson, since joining the company in 1996. Prior to Johnson & Johnson, he held various sales and marketing roles at Zimmer Biomet.

Mr. McBreen has served as a corporate advisory board member for the American Orthopaedic Society for Sports Medicine and on the Board of Trustees for the Arthroscopy Association of North America Education Foundation. He is a board member of the ThinkFirst Foundation.

Mr. McBreen completed his bachelor’s degree in business administration at Providence College.

What is Michael J. McBreen's net worth?

The estimated net worth of Michael J. McBreen is at least $1.19 million as of March 7th, 2023. Mr. McBreen owns 28,796 shares of Integra LifeSciences stock worth more than $1,187,835 as of June 7th. This net worth estimate does not reflect any other investments that Mr. McBreen may own. Learn More about Michael J. McBreen's net worth.

What is Michael J. McBreen's salary?

As the EVP of Integra LifeSciences Holdings Co., Mr. McBreen earned a total compensation package of $1,880,367.00 in 2021. Mr. McBreen earned a salary of $459,969.00, stock awards of $827,483.00, options awards of $197,007.00, non-equity compensation of $385,000.00, and other compensation of $10,908.00. Learn More on Michael J. McBreen's salary.

How do I contact Michael J. McBreen?

The corporate mailing address for Mr. McBreen and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Michael J. McBreen's contact information.

Has Michael J. McBreen been buying or selling shares of Integra LifeSciences?

Michael J. McBreen has not been actively trading shares of Integra LifeSciences in the last ninety days. Most recently, Michael J. Mcbreen sold 1,843 shares of the business's stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $54.29, for a transaction totalling $100,056.47. Following the completion of the sale, the executive vice president now directly owns 28,796 shares of the company's stock, valued at $1,563,334.84. Learn More on Michael J. McBreen's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 7,792 shares worth more than $299,992.00. In the last year, insiders at the life sciences company sold shares 7 times. They sold a total of 16,391 shares worth more than $916,864.99. The most recent insider tranaction occured on June, 1st when CEO Witte Jan De bought 7,792 shares worth more than $299,992.00. Insiders at Integra LifeSciences own 2.9% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 6/1/2023.

Michael J. McBreen Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2023Sell1,843$54.29$100,056.4728,796View SEC Filing Icon  
11/5/2021Sell3,450$71.59$246,985.50View SEC Filing Icon  
See Full Table

Michael J. McBreen Buying and Selling Activity at Integra LifeSciences

This chart shows Michael J Mcbreen's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Read More

Today's Range

Now: $41.25
Low: $40.42
High: $41.40

50 Day Range

MA: $51.13
Low: $37.95
High: $58.98

2 Week Range

Now: $41.25
Low: $37.36
High: $61.63


405,253 shs

Average Volume

592,046 shs

Market Capitalization

$3.38 billion

P/E Ratio


Dividend Yield



Yours Free! Top FIVE Dividend Stocks Right Now
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.